Literature DB >> 2274447

Cardiovascular drugs in children. II. Angiotensin-converting enzyme inhibitors in pediatric patients.

A Schneeweiss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2274447     DOI： 10.1007/BF02238367

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


× No keyword cloud information.
  41 in total

1.  The history and present status of aortic surgery in Japan, particularly for aortitis syndrome.

Authors:  S Kimoto
Journal:  J Cardiovasc Surg (Torino)       Date:  1979 Mar-Apr       Impact factor: 1.888

2.  Use of the oral angiotensin I--converting enzyme inhibitor (captopril) in childhood malignant hypertension.

Authors:  S E Oberfield; D B Case; L S Levine; R Rapaport; W Rauh; M I New
Journal:  J Pediatr       Date:  1979-10       Impact factor: 4.406

3.  Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis.

Authors:  M A Ondetti; N J Williams; E F Sabo; J Pluscec; E R Weaver; O Kocy
Journal:  Biochemistry       Date:  1971-10-26       Impact factor: 3.162

4.  Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure.

Authors:  H R Brunner; H Gavras; J H Laragh
Journal:  Lancet       Date:  1973-11-10       Impact factor: 79.321

5.  Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme.

Authors:  J G Collier; B F Robinson; J R Vane
Journal:  Lancet       Date:  1973-01-13       Impact factor: 79.321

6.  Clinical use of captopril in Takayasu's disease.

Authors:  E Grossman; B Morag; N Nussinovitch; H Boichis; A Knecht; T Rosenthal
Journal:  Arch Intern Med       Date:  1984-01

7.  Disposition of captopril in normal subjects.

Authors:  K J Kripalani; D N McKinstry; S M Singhvi; D A Willard; R A Vukovich; B H Migdalof
Journal:  Clin Pharmacol Ther       Date:  1980-05       Impact factor: 6.875

8.  Guidelines for vasodilator therapy of congestive heart failure in infants and children.

Authors:  M Artman; T P Graham
Journal:  Am Heart J       Date:  1987-04       Impact factor: 4.749

9.  Antihypertensive effect and elimination kinetics of captopril in hypertensive children with renal disease.

Authors:  A R Sinaiko; B L Mirkin; D A Hendrick; T P Green; R F O'Dea
Journal:  J Pediatr       Date:  1983-11       Impact factor: 4.406

10.  Effective use of captopril in postoperative paradoxical hypertension of coarctation of the aorta.

Authors:  A Casta; V R Conti; A Talabi; B H Brouhard
Journal:  Clin Cardiol       Date:  1982-10       Impact factor: 2.882
View more
  7 in total

Review 1.  Epidemiology, pathophysiology, clinical characteristics and management of childhood cardiorenal syndrome.

Authors:  Wasiu A Olowu
Journal:  World J Nephrol       Date:  2012-02-06

Review 2.  Pharmacologic treatment of chronic pediatric hypertension.

Authors:  Renee F Robinson; Milap C Nahata; Donald L Batisky; John D Mahan
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

3.  Captopril-induced bone marrow suppression in two cardiac patients with trisomy 21.

Authors:  M M Gleason; J S Roloff; S E Cyran; H S Weber; B G Baylen; J L Myers
Journal:  Pediatr Cardiol       Date:  1993-10       Impact factor: 1.655

4.  Multiple arterial stenoses of unknown aetiology in the coronary, cerebral, and brachial arteries.

Authors:  K Suzuki; Y Murakami; S Mimori
Journal:  Br Heart J       Date:  1993-10

Review 5.  Clinical practice: heart failure in children. Part II: current maintenance therapy and new therapeutic approaches.

Authors:  Paul F Kantor; Luc L Mertens
Journal:  Eur J Pediatr       Date:  2010-02-02       Impact factor: 3.183

6.  Acute renal failure with ACE inhibition in aortic coarctation.

Authors:  P A Woodmansey; W W Yeo; P R Jackson; L E Ramsay
Journal:  Postgrad Med J       Date:  1994-12       Impact factor: 2.401

Review 7.  ACE inhibitors in pediatric patients with heart failure.

Authors:  Kazuo Momma
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.